Amrutanjan Health Care Ltd. (AMRUTANJAN) Share Price Trades Within 2% of 52-Week Low
- August 12, 2026
- Posted by: Harsh Piplani
- Category: News
Amrutanjan Health Care Ltd. Share Price is Rs 493, and the stock is trading within 2% of its 52-week low. The company’s market capitalisation stands at Rs 1,532.55 crore.
Amrutanjan Health Care Ltd. Share Price is Rs 493 at the Univest screener qualification time of 12 August 2026 at 11:30:58 AM IST, and the stock is trading within 2% of its 52-week low. With a market capitalisation of Rs 1,532.55 crore, the move is notable because proximity to a one-year bottom often brings a stock back onto investor watchlists even when the supplied data does not establish a company-specific catalyst.
The verified event here is precise: Univest identified Amrutanjan Health Care Ltd. Share Price near its 52-week low zone based on the event-time last traded price of Rs 493. That matters because such price positioning can prompt a closer look at whether the market is discounting weaker expectations, re-rating valuations, or simply reacting to broader sector positioning. The dataset confirms the price event, but it does not assign a reason.
From an analytical standpoint, the stock now sits at an intersection of price sensitivity and fundamental scrutiny. Amrutanjan Health Care Ltd. Share Price also comes with a Healthcare sector backdrop, a Pharmaceuticals & Drugs industry comparison set, and a profitability profile that appears stronger than several benchmark medians. That combination makes the stock relevant for investors tracking valuation discipline, profitability, and relative positioning through Univest.
Amrutanjan Health Care Ltd. Share Price Today: Within 2% of 52-Week Low
| Metric | Value |
|---|---|
| LTP at 2% Qualification | Rs 493 |
| Market Capitalisation | Rs 1,532.55 crore |
| 52-Week Low Position | Trading within 2% of its 52-week low |
Amrutanjan Health Care Ltd. (AMRUTANJAN) traded at Rs 493. Reported volume was 17,231.
Amrutanjan Health Care Ltd. Share Price Today is Rs 493, which is also the exact event-qualified last traded price captured by the Univest screener at 11:30:58 AM IST on 12 August 2026. The confirmed event is that the stock is trading within 2% of its 52-week low. That does not by itself indicate a fresh breakdown or a new record low, but it does place the stock in a price zone that typically attracts heightened market attention.
When a stock trades close to its yearly low, investors usually begin separating price weakness from business quality. In this case, the supplied dataset confirms the price position and also gives enough valuation and profitability data to show why Amrutanjan Health Care Ltd. Share Price is being watched. A market capitalisation of Rs 1,532.55 crore places the company in a mid-sized listed bracket within its industry comparison set, so moves near the one-year low can quickly become relevant for both value-focused and risk-aware market participants.
The context is also important. The Healthcare sector and Pharmaceuticals & Drugs industry include a wide spread of valuations, and Amrutanjan Health Care Ltd. Share Price is now being viewed against that backdrop rather than in isolation. A stock approaching its 52-week low often draws interest because investors want to know whether valuations have compressed faster than fundamentals, or whether the market is signalling caution. That is why this price event matters on Univest, and it naturally leads into a closer look at fundamentals, profitability and sector-relative valuation.
Amrutanjan Health Care Ltd. (AMRUTANJAN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,532.55 crore |
| P/E Ratio | 26.69x |
| P/B Ratio | 4.18x |
| ROE | 32.69% |
| ROCE | 44% |
| EPS | Rs 20.03 |
| Book Value Per Share | Rs 128.06 |
| Dividend Yield | 0.92% |
Amrutanjan Health Care Ltd. was valued at a P/E ratio of 26.69x, a P/B ratio of 4.18x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of 32.69% and ROCE of 44%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Per-share and shareholder-return metrics included EPS of Rs 20.03, book value per share of Rs 128.06, dividend yield of 0.92%. Dividend yield is a current or historical ratio and does not guarantee future distributions.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 26.69x |
| Benchmark Median P/E | 18.58x |
| Benchmark Average P/E | 60.9x |
| Benchmark P/E Range | 0x to 3,374.81x |
| Company P/B Ratio | 4.18x |
| Benchmark Median P/B | 1.78x |
| Company ROE | 32.69% |
| Benchmark Median ROE | 9.93% |
| Company ROCE | 44% |
| Benchmark Median ROCE | 12.96% |
| Company Market Capitalisation | Rs 1,532.55 crore |
| Benchmark Median Market Cap | Rs 145.18 crore |
Amrutanjan Health Care Ltd. (AMRUTANJAN) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Amrutanjan Health Care Ltd. (AMRUTANJAN) has a P/E ratio of 26.69x, which is above the benchmark median of 18.58x, a difference of +43.65%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Amrutanjan Health Care Ltd. (AMRUTANJAN) has a ROE of 32.69%, which is above the benchmark median of 9.93%, a difference of +229.2%. Amrutanjan Health Care Ltd. (AMRUTANJAN) has a ROCE of 44%, which is above the benchmark median of 12.96%, a difference of +239.51%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Jagsonpal Pharmaceuticals Ltd. | JAGSNPHARM | 1,518.03 | 33.38 | 6.05 | 15.7 | 19.43 |
| Fermenta Biotech Ltd. | FERMENTA | 1,614.29 | 23.58 | 3.54 | 4.27 | 7.5 |
| Syncom Formulations (India) Ltd. | SYNCOMF | 1,353.6 | 17.88 | 3.29 | 18.04 | 20.72 |
| Windlas Biotech Ltd. | WINDLAS | 1,741.7 | 29.29 | 3.79 | 12.87 | 14.88 |
| Accent Microcell Ltd. | ACCENTMIC-SM | 1,316.88 | 30.03 | 4.78 | 20.07 | 18.78 |
Amrutanjan Health Care Ltd. (AMRUTANJAN) has a P/E ratio of 26.69x compared with the displayed peer median of 29.29x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 32.69% compares with a peer median of 15.7% across the companies shown in the table. ROCE stood at 44% versus the displayed peer median of 18.78%, providing a capital-efficiency comparison. Amrutanjan Health Care Ltd. (AMRUTANJAN) has a market capitalisation of Rs 1,532.55 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Amrutanjan Health Care Ltd.
- Amrutanjan Health Care Ltd. Share Price is Rs 493 and the stock is trading within 2% of its 52-week low, making it a notable price-action event on Univest.
- The company has a market capitalisation of Rs 1,532.55 crore, placing it above the same-industry median market cap of Rs 145.18 crore and average of Rs 476.55 crore.
- Its valuation remains meaningful at 26.69 times earnings and 4.18 times book value, even with the stock close to its yearly low.
- Profitability metrics stand out, with ROE at 32.69 and ROCE at 44, both above the same-industry medians of 9.93 and 12.96.
- Peer comparison shows stronger return ratios than Jagsonpal Pharmaceuticals, Fermenta Biotech, Syncom Formulations, Windlas Biotech and Accent Microcell.
- The supplied data confirms the price event, but does not establish a company-specific catalyst, keeping focus on valuation and relative positioning.
About Amrutanjan Health Care Ltd.
Amrutanjan Health Care Ltd. operates in the Healthcare sector and is classified within the Pharmaceuticals & Drugs industry. Based on the supplied dataset, the stock is therefore best understood within the listed Indian healthcare and pharmaceutical products ecosystem rather than through a generic consumer or industrial comparison set.
For investors tracking Amrutanjan Health Care Ltd. Share Price, that industry classification matters because valuation, profitability and market-cap comparisons are being measured against other Pharmaceuticals & Drugs companies. The same-industry benchmark includes 135 companies, while the broader Healthcare sector count stands at 195 companies. That provides a structured lens through which the company’s P/E, P/B, ROE, ROCE and market capitalisation can be interpreted.
At present, the supplied data places Amrutanjan Health Care Ltd. in a segment where returns on equity and capital employed are materially ahead of industry medians, while valuation multiples also remain above those medians. As a result, the company’s current market discussion is being shaped not just by business classification, but by the interaction between sector positioning, profitability and a share price that is now close to its one-year low.
Track Amrutanjan Health Care Ltd. Share Price on Univest
Use Amrutanjan Health Care Ltd. (AMRUTANJAN) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
Investors tracking Amrutanjan Health Care Ltd. Share Price can use Univest to follow live price movements, 52-week levels, valuation ratios, profitability metrics, peer comparisons and sector benchmarks in one place. Because the stock is trading within 2% of its 52-week low, monitoring relative valuation and return ratios becomes especially relevant.
Univest also helps users track Amrutanjan Health Care Ltd. Share Price Today alongside metrics such as P/E, P/B, ROE, ROCE, EPS, book value and dividend yield. For stocks that move close to yearly lows, having a structured view of industry medians, peer metrics and market-cap context can help investors stay focused on verified numbers rather than speculation.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is Amrutanjan Health Care Ltd. Share Price today?
Ans. Amrutanjan Health Care Ltd. Share Price was Rs 493 at the Univest event qualification time on 12 August 2026 at 11:30:58 AM IST. The stock was also identified as trading within 2% of its 52-week low.
Why is Amrutanjan Health Care Ltd. Share Price in focus today?
Ans. Amrutanjan Health Care Ltd. Share Price is in focus because the stock is trading within 2% of its 52-week low. The supplied data confirms the price event and shows a market capitalisation of Rs 1,532.55 crore.
Is Amrutanjan Health Care Ltd. near its 52-week low?
Ans. Yes, the Univest screener identifies Amrutanjan Health Care Ltd. Share Price as trading within 2% of its 52-week low. The event-qualified last traded price recorded in the supplied data is Rs 493.
What is the market capitalisation of Amrutanjan Health Care Ltd.?
Ans. Amrutanjan Health Care Ltd. has a market capitalisation of Rs 1,532.55 crore. Within the same-industry benchmark, that is above the median of Rs 145.18 crore and the average of Rs 476.55 crore.
What do the valuation ratios of Amrutanjan Health Care Ltd. show?
Ans. Amrutanjan Health Care Ltd. trades at a P/E of 26.69 and a P/B of 4.18. Both are above the same-industry medians of 18.58 and 1.78, showing valuation multiples above the benchmark midpoint.
What are the EPS, book value and dividend yield of Amrutanjan Health Care Ltd.?
Ans. The supplied figures show EPS of 20.03, book value per share of Rs 128.06 and dividend yield of 0.92. Together, these numbers provide earnings, balance-sheet and payout context for the stock.
How does Amrutanjan Health Care Ltd. compare with selected peers?
Ans. Compared with Jagsonpal, Fermenta, Syncom, Windlas and Accent Microcell, Amrutanjan Health Care Ltd. shows stronger ROE and ROCE than each supplied peer, while its P/E and P/B sit in the middle of the group.
Which sector and industry does Amrutanjan Health Care Ltd. belong to?
Ans. Amrutanjan Health Care Ltd. belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied benchmark scope uses 135 same-industry companies, while the wider sector set includes 195 companies.
Where can investors track Amrutanjan Health Care Ltd. Share Price?
Ans. Investors can track Amrutanjan Health Care Ltd. Share Price on Univest for live price moves, 52-week levels, valuation ratios, peer comparison and broader market insights. That is especially useful when the stock is near a yearly low.
